z-logo
Premium
Characterization of in vivo antioxidant constituents and dual‐standard quality assessment of Danhong injection
Author(s) -
Liu HaiTao,
Wang YueFei,
Olaleye Olajide,
Zhu Yan,
Gao XiuMei,
Kang LiYuan,
Zhao Tao
Publication year - 2013
Publication title -
biomedical chromatography
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.4
H-Index - 65
eISSN - 1099-0801
pISSN - 0269-3879
DOI - 10.1002/bmc.2842
Subject(s) - chemistry , dpph , antioxidant , chromatography , high performance liquid chromatography , liquid chromatography–mass spectrometry , mass spectrometry , biochemistry
Antioxidants and oxidative stress play a critical role in cardiovascular diseases. Danhong injection (DHI) is a well prescribed cardiovascular medication in China, but its detailed chemical basis and mechanisms of action remain unknown. To prove the antioxidant activity of DHI, its free radical scavenging capacity (RSC) was assessed by 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) spectrophotometric assay. The 50% radical scavenging activity value was 1:129.2 mL/mL, against 0.95 m m DPPH. To further identify the antioxidant compounds, modified thin‐layer chromatography combined with DPPH bioautography assay was used. Compared with vitamin C, 11 of 16 available compounds displayed strong antioxidant activity, which were also detected in rat serum after intravenous administration of DHI by ultra‐performance liquid chromatography–tandem mass spectrometry, except for hydroxysafflor yellow A. Therefore, 10 antioxidants remaining in the blood as key markers, and six other compounds as general markers, were employed to perform the quality control of DHI by ultra‐performance liquid chromatography–ultraviolet detection after systematic methodological validation. The analytical results indicate a high correlation ( r  = 0.9) between the total content of those antioxidants remaining in blood and RSC of DHI among 10 batches. Further, the antioxidant profiling and chemical marker quantification as dual‐standard quality assessment was successfully applied to evaluate Danshen and safflower injections. Copyright © 2012 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here